#USA #oncology #Little Rock #DeepScribe #CARTI

CARTI Cancer Center Enhances Oncology Care with AI Technology

CARTI Cancer Center, a notable not-for-profit organization in Arkansas, has recently announced its collaboration with DeepScribe, a leader in ambient artificial intelligence tailored for oncology care. This partnership marks a significant step in revolutionizing the documentation process within CARTI's practices across its 18 facilities statewide.

Innovating Patient Care through AI

DeepScribe’s ambient AI technology allows clinicians to focus more on patient interactions by significantly reducing their documentation workload. According to Matthew Ko, the CEO and Co-founder of DeepScribe, this partnership provides the tools necessary for clinicians to cultivate more meaningful relationships with their patients. He remarked, “This partnership eliminates the weight of documentation for CARTI oncologists, giving them the insights and room to nurture those relationships that are pivotal to effective care.”

The ambient operating system not only streamlines documentation but also offers valuable insights such as HCC risk capture guidance and E/M coding recommendations. This helps to alleviate the usual administrative load that oncologists face, enabling them to devote more time to critical patient care.

A Mission Rooted in Compassion

Carson Seelinger, the Chief Information Officer at CARTI, emphasized the significance of this partnership in relation to CARTI’s mission to deliver accessible and trusted cancer care to all patients. “By collaborating with DeepScribe, we are empowering our clinicians with AI technology specifically designed for oncology. This partnership enables our teams to focus on what truly matters — our patients — while making a substantial impact across Arkansas.”

The integration with Flatiron Health's OncoEMR® enhances the capability of DeepScribe’s ambient AI, which goes beyond mere documentation and incorporates a contextual understanding of patients' histories. This contextually aware documentation ensures that the quality and relevance of the information capture enhance clinical intelligence.

DeepScribe's Commitment to Oncology

DeepScribe's leadership in the oncology space stems from years of refinement and collaboration with key industry stakeholders. The platform’s oncology-specific workflows and terminology understanding make it a powerful tool in managing one of the most complex fields in medicine. Dr. Dean Dalili, DeepScribe’s Chief Medical Officer, stated that while immediate benefits include reductions in the daily stresses of documentation for clinicians, the long-term value resides in how each documented interaction contributes to a broader dataset that enhances future patient care and decision-making.

“Each recorded interaction becomes a vital source for insights and long-term intelligence that can benefit organizations like CARTI immensely,” he added. This sentiment reinforces DeepScribe’s role as essential not just in streamlining daily documentation processes, but also in supporting ongoing patient management and decision-making.

About CARTI and DeepScribe

CARTI has positioned itself as a leader in integrated cancer care, offering advanced treatments in medical, radiation, and surgical oncology, among other specialties. Their dedication to compassionate, innovative care mirrors the ethos at DeepScribe, which is focused on creating customized AI solutions to improve clinician documentation efficiency and satisfaction. Founded in 2017, DeepScribe’s commitment to developing AI tools that cater to the nuances of chronic care workflows has gained industry recognition, including achieving a noteworthy performance score by KLAS Research.

To learn more about how CARTI is advancing cancer care and how DeepScribe is enhancing clinical operations, visit CARTI's official website and explore how AI is reshaping the healthcare landscape.